SynopsisAlan, a French health tech company, has successfully attracted a whopping $460 million investment from the Netherlands-based Prosus, elevating its valuation to an impressive $6.3 billion. This funding will significantly enhance Alan's growth efforts, promoting global expansion and driving innovation in AI-powered products. Additionally, the agreement grants Alan access to Prosus's Large Commerce Model, enabling improved health insurance and telehealth services in its existing markets.Dutch investment company Prosus has invested $460 million into French health tech company Alan, valuing the startup at $6.3 billion, the company ‌said ⁠on Wednesday.Alan operates ⁠in France, Canada, Belgium and Spain and offers services such as health insurance and telehealth. The company has an annual recurring revenue ⁠of 800 ‌million euros ($909.04 million) as of the first ⁠quarter of 2026.* The investment ​will consist of both ​primary and secondary equity* It will help drive Alan's expansion in international markets and accelerate its ‌AI-led product development* Prosus will also provide ​Alan ​with access ⁠to its Large Commerce Model* The transaction's closing is subject to applicable regulatory approvals, including from French financial authorities($1 = 0.8800 euros) ...moreElevate your knowledge and leadership skills at a cost cheaper than your daily tea.Subscribe Now